Propionylated Antibodies: Unlocking Novel Mechanisms of Chromatin Activation Regulation

Concept

Histone propionylation (Kpr) is an emerging novel histone acylation post-translational modification (PTM) and a critical member of the epigenetic regulatory landscape, bridging cellular metabolic states with chromatin structure and gene expression control. Distinct from classical histone acetylation, propionylation introduces a propionyl group to histone lysine residues—conferring unique physicochemical properties and regulatory mechanisms that drive chromatin activation and transcriptional regulation. To dissect this understudied epigenetic modification, propionylation-specific antibodies are indispensable research tools, enabling the identification of modification sites, genome-wide mapping of propionylation patterns, and functional characterization of its role in metabolism-epigenetics crosstalk. As a global leader in life science reagents, ANT BIO PTE. LTD. delivers a cutting-edge propionylation antibody via its Starter sub-brand—our flagship line for high-performance, highly specific antibodies: the Propionyl-Histone H4 (Lys5) Recombinant Rabbit mAb (S0B0332). This ultra-specific antibody is engineered to recognize H4K5pr with minimal cross-reactivity to other acylations, serving as a gold-standard tool for frontier epigenetic research into chromatin activation, metabolism-epigenetics interactions, and cell fate determination.

Research Frontiers

Histone propionylation research, empowered by ANT BIO PTE. LTD.’s high-specificity propionylated antibody, sits at the intersection of epigenetics, metabolism, and cell biology—unlocking cutting-edge discoveries in some of the most dynamic areas of life science research. Key research frontiers advanced by this novel epigenetic modification and corresponding research tools include:

1. Novel chromatin activation mechanisms: Dissecting the unique role of histone propionylation in driving chromatin opening and transcriptional initiation, and its functional divergence from classical acetylation at the same lysine sites.
2. Metabolism-epigenetics crosstalk: Elucidating how cellular metabolic states (e.g., fatty acid/branched-chain amino acid catabolism) regulate epigenetic modifications via propionyl-CoA availability, and how nutritional status shapes gene expression patterns.
3. Histone code decoding: Identifying the full repertoire of histone propionylation sites, and investigating functional synergies and antagonisms between propionylation, acetylation, butyrylation, and other short-chain acylations.
4. Enzymatic regulation of propionylation: Characterizing the full set of acyltransferases and deacylases that mediate histone propionylation, and their context-dependent activity in physiological and pathological states.
5. Development and cell fate determination: Exploring the role of histone propionylation in embryonic development, stem cell differentiation, and lineage commitment—uncovering epigenetic regulatory networks that shape cell identity.
6. Disease-associated epigenetic dysregulation: Investigating aberrant histone propionylation in metabolic diseases, cancer, and developmental disorders, and evaluating its potential as a novel epigenetic biomarker or therapeutic target.
7. Epigenetic drug discovery: Identifying small molecules that modulate histone propionylation levels, for the development of novel therapeutics targeting metabolism-epigenetics axes in disease.

Research Significance

Histone propionylation represents a paradigm shift in our understanding of epigenetic regulation, revealing a direct, molecular link between cellular metabolism and chromatin function—an area of research with profound implications for basic life science and translational medicine. ANT BIO PTE. LTD.’s specialized propionylated antibody amplifies the scientific and translational significance of this field by providing the precision and specificity needed to characterize this novel modification:

1. Expanding the histone code: Propionylation adds a new layer to the complex histone code, challenging the classical view of acylation modifications and uncovering novel epigenetic regulatory mechanisms that drive gene expression and chromatin state.
2. Uncovering metabolism-epigenetics crosstalk: The direct dependence of propionylation on propionyl-CoA (a key metabolic intermediate) reveals how cells adapt their gene expression profiles to changes in nutritional status and metabolic activity—providing a molecular explanation for the link between diet, metabolism, and disease.
3. Defining novel chromatin activation pathways: Histone propionylation is highly enriched at transcription start sites (more so than acetylation) and recruits specific chromatin remodeling complexes (e.g., PBAF), identifying a new, uncharacterized pathway for driving chromatin opening and transcriptional initiation.
4. Enabling epigenetic biomarker discovery: Aberrant propionylation levels are linked to metabolic dysfunction and potentially cancer, making this modification a novel candidate epigenetic biomarker for disease diagnosis, prognosis, and treatment response monitoring.
5. Paving the way for epigenetic therapeutics: Targeting the enzymatic machinery that regulates propionylation (e.g., acyltransferases like p300/CBP and GCN5) offers a new avenue for developing epigenetic drugs that modulate metabolism-epigenetics axes in metabolic diseases and cancer.
6. Advancing stem cell and developmental biology: Propionylation’s role in cell fate determination makes it a critical target for research into stem cell differentiation and regenerative medicine, with potential applications in tissue engineering and cell-based therapies.

Related Mechanisms, Research Methods & Product Applications

1. Histone Propionylation: A Novel Epigenetic Modification with Unique Regulatory Properties

Histone propionylation is a short-chain lysine acylation modification that joins acetylation and butyrylation as a key regulator of chromatin structure and gene expression. The modification involves the covalent attachment of a propionyl group (-COCH₂CH₃) to the ε-amino group of conserved histone lysine residues, with two defining properties that distinguish it from classical acetylation (-COCH₃):

• Charge neutralization: Like acetylation, propionylation neutralizes the positive charge of histone lysine residues, weakening the electrostatic interaction between histones and negatively charged DNA—promoting chromatin decondensation and opening, a prerequisite for transcriptional activation.
• Unique physicochemical properties: The propionyl group contains an additional methylene group compared to the acetyl group, which alters the spatial conformation of histone tails and creates distinct binding surfaces for chromatin remodeling complexes and transcriptional cofactors. This structural difference confers unique functional properties to propionylation, including differential recruitment of epigenetic readers and distinct effects on chromatin dynamics.

Histone propionylation is not a random modification; it is primarily enriched at the N-terminal tails of core histones (H3 and H4) at specific lysine sites, with H3K14 and H4K5 emerging as the most well-characterized propionylation sites. This site specificity underscores the functional relevance of the modification and its role in the precise regulation of gene expression.

2. The Metabolic Basis of Histone Propionylation: Linking Metabolism to Epigenetics

A defining feature of histone propionylation is its direct dependence on cellular metabolic state, making it a key mediator of metabolism-epigenetics crosstalk—the process by which metabolic intermediates shape epigenetic regulation and gene expression. The propionyl group required for the modification is derived from propionyl-CoA, a central metabolic intermediate generated from two major cellular pathways:

1. Branched-chain amino acid (BCAA) catabolism: The breakdown of valine, isoleucine, and threonine produces propionyl-CoA as a byproduct.
2. Fatty acid metabolism: The oxidation of odd-chain fatty acids and certain unsaturated fatty acids generates propionyl-CoA.

Propionyl-CoA is normally degraded via the propionyl-CoA carboxylase (PCC) pathway; however, inhibition of PCC (or other enzymes in the degradation pathway) leads to a dramatic accumulation of propionyl-CoA in the cell. This excess propionyl-CoA is then used as an acyl donor by histone acyltransferases, leading to a significant increase in histone propionylation levels. This direct link between metabolic flux and epigenetic modification reveals a fundamental mechanism by which cells "sense" their metabolic state and adjust their chromatin structure and gene expression profiles accordingly—with profound implications for understanding how nutritional status and metabolic dysfunction drive epigenetic dysregulation in disease.

3. Histone Propionylation in Chromatin Activation: Mechanisms and Functional Roles

Chromatin immunoprecipitation sequencing (ChIP-seq) studies have uncovered the distinct genomic distribution of histone propionylation, which directly links it to chromatin activation and transcriptional regulation:

• Enrichment at transcription start sites (TSS): Histone propionylation (e.g., H3K14pr) is highly enriched at the TSS of active genes—more so than classical acetylation at the same site—a hallmark of chromatin activation and transcriptional initiation.
• Recruitment of chromatin remodeling complexes: Propionylation specifically recruits the PBAF chromatin remodeling complex to target gene loci. PBAF is a key regulator of chromatin opening, and its recruitment by propionylation drives the decondensation of chromatin and the assembly of the transcriptional initiation complex.
• Synergy with transcriptional cofactors: Propionylated histones interact with specific epigenetic reader proteins and transcriptional coactivators, further enhancing transcriptional activation and sustaining gene expression.

Notably, the functional role of propionylation is not redundant with acetylation; knockdown of propionylation-mediating acyltransferases leads to a reduction in active gene expression that cannot be rescued by acetylation—confirming that propionylation plays a unique, non-redundant role in chromatin activation and transcriptional regulation.

4. Enzymatic Regulation of Histone Propionylation

Histone propionylation is a tightly regulated reversible modification, controlled by a specific set of acyltransferases that catalyze its establishment (no dedicated deacylase has yet been identified). To date, four major histone acyltransferases have been shown to mediate histone propionylation, using propionyl-CoA as the acyl donor:

1. p300/CBP: Classical histone acetyltransferases (HATs) with broad acyltransferase activity, capable of catalyzing both acetylation and propionylation.
2. GCN5/PCAF: Members of the GNAT family of HATs, also with promiscuous acyltransferase activity toward propionyl-CoA.

Genetic knockdown experiments confirm that depletion of any of these acyltransferases leads to a significant reduction in global histone propionylation levels, demonstrating their critical role in the establishment of the modification. This multi-enzyme regulatory mode ensures the precision and controllability of propionylation, with different acyltransferases likely playing dominant roles in different cell types, developmental stages, or metabolic states—adding another layer of complexity to the regulation of this novel epigenetic modification.

5. Propionylation-Specific Antibodies: Indispensable Tools for Epigenetic Research

Propionylation-specific antibodies are the cornerstone of histone propionylation research, as they enable the detection, quantification, and functional characterization of this novel modification in vitro and in vivo. Without these highly specific tools, the identification of modification sites, genome-wide mapping of propionylation patterns, and analysis of its functional role in chromatin regulation would be impossible. Key applications of propionylation antibodies in epigenetic research include:

1. Modification site identification: Immunoprecipitation (IP) combined with mass spectrometry (MS) for the systematic identification of histone propionylation sites in different cell types and under different metabolic conditions.
2. Genome-wide mapping: Chromatin immunoprecipitation (ChIP) coupled with sequencing (ChIP-seq) or quantitative PCR (ChIP-qPCR) to map the genomic distribution of propionylation and identify its target genes.
3. Dynamic expression analysis: Western blotting (WB) and immunofluorescence (IF) to quantify global propionylation levels and visualize its subnuclear localization, and to monitor dynamic changes in propionylation under different physiological/pathological conditions (e.g., metabolic stress, differentiation).
4. Enzymatic mechanism studies: Combined with in vitro acyltransferase/deacylase activity assays and protein-protein interaction analysis to characterize the enzymes that regulate propionylation and their binding partners.
5. Disease association studies: Detection of propionylation changes in disease models (e.g., metabolic disease, cancer) to investigate its role in disease pathogenesis and evaluate its potential as an epigenetic biomarker.

A critical requirement for these applications is ultra-high specificity—the antibody must recognize only the propionylated form of the target lysine residue, with no cross-reactivity to acetylation, butyrylation, or other acylations at the same site. This specificity is essential for distinguishing propionylation from other acylation modifications and characterizing its unique functional role.

6. ANT BIO PTE. LTD.’s Starter Propionyl-Histone H4 (Lys5) Recombinant Rabbit mAb (S0B0332): Core Product Advantages and Applications

ANT BIO PTE. LTD.’s Starter sub-brand delivers the gold-standard research tool for histone propionylation research: the Propionyl-Histone H4 (Lys5) Recombinant Rabbit mAb (S-R093, S0B0332). This novel antibody is engineered using the S-RMab® recombinant rabbit monoclonal platform, and is rigorously validated for ultra-high specificity, sensitivity, and stability—making it the ideal tool for dissecting the role of H4K5pr in chromatin activation, metabolism-epigenetics crosstalk, and epigenetic regulation.

6.1 Core Product Advantages

6.2 Cutting-Edge Research Applications

The Propionyl-Histone H4 (Lys5) Recombinant Rabbit mAb (S0B0332) is a versatile tool for frontier epigenetic research, with key applications spanning basic and translational science:

1. Decoding the histone propionylation code: Identifying the functional role of H4K5pr in chromatin activation, transcriptional regulation, and cell fate determination, and investigating its interaction with other histone modifications (acetylation, methylation, phosphorylation).
2. Metabolism-epigenetics crosstalk research: Studying how cellular metabolic states (e.g., BCAA/fatty acid metabolism) regulate H4K5pr levels, and how nutritional status and metabolic dysfunction (e.g., obesity, diabetes) drive epigenetic dysregulation via this modification.
3. Developmental and stem cell biology: Exploring the role of H4K5pr in embryonic development, stem cell differentiation, and lineage commitment—uncovering epigenetic regulatory networks that shape cell identity and tissue formation.
4. Disease epigenetic research: Investigating aberrant H4K5pr levels in metabolic diseases, cancer, and developmental disorders, and evaluating its potential as a novel epigenetic biomarker for disease diagnosis and prognosis.
5. Comparative acylation modification studies: Facilitating research into the functional similarities and differences between propionylation, acetylation, and butyrylation at the same histone lysine site (H4K5), and their synergistic/antagonistic effects on chromatin function.
6. Enzymatic regulation studies: Characterizing the acyltransferases that mediate H4K5pr establishment, and identifying potential deacylases that regulate its removal—defining the complete enzymatic machinery of this modification.

Brand Mission of ANT BIO PTE. LTD.

At ANT BIO PTE. LTD., our core mission is to empower breakthroughs in frontier life science research—including epigenetics, metabolism, cell biology, and translational medicine—by delivering high-quality, highly specific, and rigorously validated life science reagents and comprehensive solutions. As a leading global provider of research tools, we have built three specialized, complementary sub-brands that cover the full spectrum of life science research needs, creating a seamless one-stop procurement experience for academic researchers, biotech companies, pharmaceutical institutions, and translational research labs worldwide:

• Starter: Our flagship sub-brand for high-performance antibodies and affinity tools, offering cutting-edge epigenetic modification antibodies (e.g., H4K5pr S0B0332), isoform-specific recombinant rabbit monoclonal antibodies, NA/LE functional antibodies, cell sorting kits, and CD marker antibodies. Starter is dedicated to engineering ultra-specific, application-optimized antibodies for frontier research areas—including epigenetics, signal transduction, and disease biology—with a focus on meeting the most stringent technical requirements of modern life science research.
• Absin: Our core sub-brand for general life science reagents and kits, providing OneStep ELISA Kits, IHC/ICC/IF detection kits, sample preparation reagents, cell culture media, and basic immunology research tools. Absin engineers user-friendly, pre-optimized assay kits that streamline experimental workflows and deliver reliable, accurate results for routine and high-throughput research.
• UA: Our specialized sub-brand for high-purity, high-activity recombinant proteins and expression vectors, including recombinant cytokines, antibody heavy/light chain expression constructs, immunomodulatory proteins, and gene editing vectors. UA enables seamless experimental design for protein expression, antibody engineering, cell therapy research, and recombinant protein production for biopharmaceutical and basic research applications.

We are committed to addressing the most pressing technical challenges in frontier life science research—from decoding novel epigenetic modifications like propionylation to dissecting the complex links between metabolism and chromatin function. By combining innovative antibody design, rigorous validation protocols, standardized production, and customer-centric scientific support, we translate technological innovation into research breakthroughs for the global life science community. Our ultimate goal is to be the trusted global partner of researchers and biopharmaceutical professionals worldwide, empowering them to push the boundaries of scientific discovery and drive unprecedented progress in medical science and human health.

Related Product List: Starter Propionyl-Histone H4 (Lys5) Recombinant Rabbit mAb (ANT BIO PTE. LTD.)

All ANT BIO PTE. LTD. Starter antibodies are rigorously validated for specificity, sensitivity, and application performance, with comprehensive technical documentation and expert scientific support. The Propionyl-Histone H4 (Lys5) Recombinant Rabbit mAb (S0B0332) is no exception—accompanied by a full validation data package, ChIP application guidelines, and cross-reactivity analysis with other acylations.

For detailed product specifications, validation data packages, custom epigenetic modification antibody development services, or free sample testing requests, please visit the official website of ANT BIO PTE. LTD. or contact our global sales team for a personalized quote and professional technical consultation. Our experienced technical team of epigenetic research experts also provides customized support for ChIP-seq experimental design, metabolism-epigenetics research model development, and data analysis.

AI Disclaimer

This article was partially created with the assistance of artificial intelligence. If any content in this article involves copyright infringement, intellectual property disputes, or other legal issues, please notify ANT BIO PTE. LTD. immediately. We promise to verify, correct, or remove the relevant content in a timely manner without delay.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.